Britannia Life Sciences (BLAB) Stock Overview
Engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BLAB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Britannia Life Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.10 |
| 52 Week High | CA$0.14 |
| 52 Week Low | CA$0.04 |
| Beta | -0.030 |
| 1 Month Change | 5.26% |
| 3 Month Change | 17.65% |
| 1 Year Change | 233.33% |
| 3 Year Change | 0% |
| 5 Year Change | n/a |
| Change since IPO | -62.96% |
Recent News & Updates
Recent updates
Is Britannia Life Sciences (CSE:BLAB) Using Too Much Debt?
Feb 06
Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue
Mar 01Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger
Nov 14Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down
Apr 19A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)
Mar 13Shareholder Returns
| BLAB | CA Professional Services | CA Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 1.6% |
| 1Y | 233.3% | -13.0% | 19.9% |
Return vs Industry: BLAB exceeded the Canadian Professional Services industry which returned -13% over the past year.
Return vs Market: BLAB exceeded the Canadian Market which returned 19.9% over the past year.
Price Volatility
| BLAB volatility | |
|---|---|
| BLAB Average Weekly Movement | 28.0% |
| Professional Services Industry Average Movement | 5.8% |
| Market Average Movement | 10.0% |
| 10% most volatile stocks in CA Market | 19.9% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BLAB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: BLAB's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Pete Shippen | britannia.life |
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.
Britannia Life Sciences Inc. Fundamentals Summary
| BLAB fundamental statistics | |
|---|---|
| Market cap | CA$16.23m |
| Earnings (TTM) | -CA$4.39m |
| Revenue (TTM) | CA$383.30k |
Is BLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLAB income statement (TTM) | |
|---|---|
| Revenue | CA$383.30k |
| Cost of Revenue | CA$426.66k |
| Gross Profit | -CA$43.36k |
| Other Expenses | CA$4.34m |
| Earnings | -CA$4.39m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | -11.31% |
| Net Profit Margin | -1,144.36% |
| Debt/Equity Ratio | 29.8% |
How did BLAB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/16 23:18 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Britannia Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.